DermQuest logo

For Healthcare Professionals Only

Newsletter |  Editorial Board |  Contact Us |  Log in |  Register |  Help
 
The art, science and practice of dermatology

Forgotten login details?
Not yet a Member?

Video Channels


The Latest from Dermquest

Clinical Updates

Depigmentation therapy for vitiligo

18 January 2012

Tiffany T Mayo, MS, and Amit G Pandya, MD

Most patients with vitiligo desire repigmentation of the affected area(s). This article discusses the use, mechanisms of action and side effects of several depigmentation therapies in patients with vitiligo.

Practice Management

How can we better communicate drug safety risks to patients?

14 December 2011

Steven R Feldman, MD

This articles discusses the importance of communicating the risk of drug side effects clearly and accurately to patients, in order to avoid unnecessary worry about the magnitude of such risks and potential discontinuation of treatment regimens.

News Headlines

Morgellons noninfectious, no environmental cause

27 January 2012

An investigation into the unexplained skin condition known as “Morgellons” finds no evidence to suggest that it is infectious or caused by an environmental source.

Key factors involved in skin inflammation discovered

27 January 2012

Researchers have identified a cellular “gatekeeper” that when destroyed can trigger atopic dermatitis and myeloproliferative disorders.

ADAM33 gene variants associated with psoriasis

27 January 2012

Variants in a disintegrin and metalloproteinase 33 gene are associated with psoriasis in Han Chinese people, suggest study results.

Monthly Poll

Do you offer depigmentation therapy for your patients with severe vitiligo?

View all polls